These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 7508973)
1. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. Tsai JF; Chang WY; Jeng JE; Ho MS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Tsai JH J Med Virol; 1993 Dec; 41(4):296-300. PubMed ID: 7508973 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and hepatitis C virus infection among chronic alcoholic patients with liver disease in Taiwan. Chang TT; Lin CY; Chow NH; Hsu PI; Yang CC; Lin XZ; Shin JS; Chen DS J Formos Med Assoc; 1994 Feb; 93(2):128-33. PubMed ID: 7912583 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. Chen DS; Kuo GC; Sung JL; Lai MY; Sheu JC; Chen PJ; Yang PM; Hsu HM; Chang MH; Chen CJ J Infect Dis; 1990 Oct; 162(4):817-22. PubMed ID: 2169497 [TBL] [Abstract][Full Text] [Related]
6. Low prevalences of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: a case control study. Chien RN; Sheen IS; Liaw YF J Gastroenterol Hepatol; 1993; 8(6):574-6. PubMed ID: 7506585 [TBL] [Abstract][Full Text] [Related]
7. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis. Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245 [TBL] [Abstract][Full Text] [Related]
8. Superinfection with hepatitis C virus in hemodialysis patients with hepatitis B surface antigenemia: its prevalence and clinical significance in Taiwan. Chen KS; Lo SK; Lee N; Leu ML; Huang CC; Fang KM Nephron; 1996; 73(2):158-64. PubMed ID: 8773337 [TBL] [Abstract][Full Text] [Related]
10. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH J Hepatol; 1996 Mar; 24(3):271-6. PubMed ID: 8778192 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea. Kwon SY; Ahn MS; Chang HJ J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222 [TBL] [Abstract][Full Text] [Related]
12. Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia. Bile K; Aden C; Norder H; Magnius L; Lindberg G; Nilsson L Scand J Infect Dis; 1993; 25(5):559-64. PubMed ID: 7506842 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH Int J Cancer; 1994 Mar; 56(5):619-21. PubMed ID: 8314335 [TBL] [Abstract][Full Text] [Related]
14. The role of hepatitis C virus in chronic hepatitis B virus infection. Chuang WL; Chang WY; Lu SN; Lin ZY; Chen SC; Hsieh MY; Wang LY; You SL; Chen CJ Gastroenterol Jpn; 1993 May; 28 Suppl 5():23-7. PubMed ID: 7689504 [TBL] [Abstract][Full Text] [Related]
15. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Tsai JF; Jeng JE; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH Br J Cancer; 1996 Jun; 73(12):1498-502. PubMed ID: 8664119 [TBL] [Abstract][Full Text] [Related]
16. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features. Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to hepatitis E virus among Chinese patients with acute hepatitis in Taiwan. Tsai JF; Jeng JE; Chang WY; Lin ZY; Tsai JH J Med Virol; 1994 Aug; 43(4):341-4. PubMed ID: 7525864 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in chronic liver disease in Natal. Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789 [TBL] [Abstract][Full Text] [Related]
19. Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan. Wang CS; Chang TT; Chou P J Clin Epidemiol; 1998 Sep; 51(9):733-8. PubMed ID: 9731921 [TBL] [Abstract][Full Text] [Related]
20. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B. Villa E; Grottola A; Buttafoco P; Trande P; Merighi A; Fratti N; Seium Y; Cioni G; Manenti F Dig Dis Sci; 1995 Jan; 40(1):8-13. PubMed ID: 7529674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]